IRAK4-IN-15

Modify Date: 2024-01-02 17:20:22

IRAK4-IN-15 Structure
IRAK4-IN-15 structure
Common Name IRAK4-IN-15
CAS Number 2667681-85-6 Molecular Weight 488.56
Density N/A Boiling Point N/A
Molecular Formula C25H29FN10 Melting Point N/A
MSDS N/A Flash Point N/A

 Use of IRAK4-IN-15


IRAK4-IN-15 (compound 35) is a potent and selective IRAK4 inhibitor with an IC50 of 0.002 µM. IRAK4-IN-15 shows good human PK predictions with low intrinsic clearance. IRAK4-IN-15 shows great synergistic in vitro activity against MyD88/CD79 double mutant ABC-DLBCL in combination with Acalabrutinib. [1].

 Names

Name IRAK4-IN-15

 IRAK4-IN-15 Biological Activity

Description IRAK4-IN-15 (compound 35) is a potent and selective IRAK4 inhibitor with an IC50 of 0.002 µM. IRAK4-IN-15 shows good human PK predictions with low intrinsic clearance. IRAK4-IN-15 shows great synergistic in vitro activity against MyD88/CD79 double mutant ABC-DLBCL in combination with Acalabrutinib. [1].
Related Catalog
Target

IRAK4:0.002 μM (IC50)

In Vitro IRAK4-IN-15 (compound 35) shows cell pIRAK4 potencies with an IC50 of 0.21 µM[1]. IRAK4-IN-15 (compound 35) shows selectivity with IC50s of 0.002,1.2, >10,1.5, 0.23, 0.48, 0.93, 0.57 µM for IRAK4, IRAK1, BTK, Flt3, PI3Kδ, TRKa, TRKb, TRKc, respectively[1].
References

[1]. Degorce SL, et al. Improving metabolic stability and removing aldehyde oxidase liability in a 5-azaquinazoline series of IRAK4 inhibitors. Bioorg Med Chem. 2020 Dec 1;28(23):115815.

 Chemical & Physical Properties

Molecular Formula C25H29FN10
Molecular Weight 488.56